SBP Group Eyes Innovation as It Shifts Beyond Generics

Source: bloombergMarkets June 22, 2026 · 20:44
SBP Group CEO Eric Tse discusses his outlook for China's healthcare sector and how one of China's old-guard pharmaceutical players aims to transition from generics focused model to drug development. He speaks with Stephen Engle from the sidelines of 'The World Economic Forum's Annual Meeting of the New Champions' in Dalian. (Source: Bloomberg)

The original article opens on the publisher's website.

More from Economy

View topic →
Countries mentioned